IFNG and colitis: A very recent study revealed that oral treatment with the iron chelating compound deferasirox alleviated acute dextran sulfate sodium (DSS) induced colitis that was accompanied by decreased IFN-γ serum concentrations (Wu et al., 2023), further underscoring the immune-modulatory effects of iron deprivation in acute intestinal inflammation including campylobacteriosis as shown for deferoxamine in our present and earlier studies (Bereswill et al., 2022).